$23.08
00.00%
Pre-Market: Jul 19, 5:07 PM EDT
15 minutes delayed
Comments
Loading...
Syndax Pharmaceuticals
SNDXNASDAQ
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock, Insider Trading Activity
Syndax Pharmaceuticals: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Syndax Pharmaceuticals Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On June 17, 2024, Keith Goldan, the company's CHIEF FINANCIAL OFFICER purchased 1.25K shares for $20.03 each.
Ownership Statistics for Syndax Pharmaceuticals Inc
Institutional Shares Held
37.638M
Institutional Percentage Held
44.3%
| Jun 17, 2024 | Keith Goldan | CHIEF FINANCIAL OFFICER | 1.25K | $20.03 | $25.04K | BUY | 2.43% | 52.62K | Jun 14 | View |
| Aug 10, 2023 | Briggs Morrison | — | 0.00 | $13.52 | -$501.86K | SELL-OPTIONS | 0.00% | 17.84K | Aug 09 | View |
| Aug 03, 2023 | William Meury | — | 0.00 | $14.24 | -$1.03M | SELL-OPTIONS | 0.00% | 48.00K | Aug 02 | View |
| Jul 11, 2023 | Briggs Morrison | — | 0.00 | $14.58 | -$614.53K | SELL-OPTIONS | 0.00% | 17.84K | Jul 10 | View |
| Jun 14, 2023 | Keith Goldan | CHIEF FINANCIAL OFFICER | -577.00 | $22.31 | -$12.87K | SELL | -18.00% | 2.63K | Jun 13 | View |
| Jun 09, 2023 | Briggs Morrison | — | 0.00 | $14.42 | -$714.63K | SELL-OPTIONS | 0.00% | 17.84K | Jun 09 | View |
| May 10, 2023 | Briggs Morrison | — | 0.00 | $13.89 | -$794.26K | SELL-OPTIONS | 0.00% | 17.84K | May 09 | View |
| Apr 12, 2023 | Briggs Morrison | — | 0.00 | $12.95 | -$695.02K | SELL-OPTIONS | 0.00% | 17.84K | Apr 10 | View |
| Mar 14, 2023 | Briggs Morrison | PRESIDENT, HEAD R&D | 0.00 | $14.45 | -$853.47K | SELL-OPTIONS | 0.00% | 17.84K | Mar 13 | View |
| Feb 17, 2023 | Peter Ordentlich | CHIEF SCIENTIFIC OFFICER | 0.00 | $16.40 | -$472.30K | SELL-OPTIONS | 0.00% | 0.00 | Feb 15 | View |
| Feb 08, 2023 | Michael A Metzger | CHIEF EXECUTIVE OFFICER | 0.00 | $17.01 | -$126.68K | SELL-OPTIONS | 0.00% | 17.66K | Feb 06 | View |
| Feb 08, 2023 | Briggs Morrison | PRESIDENT, HEAD R&D | 0.00 | $16.60 | -$1.08M | SELL-OPTIONS | 0.00% | 17.84K | Feb 06 | View |
| Feb 03, 2023 | Peter Ordentlich | CHIEF SCIENTIFIC OFFICER | 0.00 | $22.87 | -$766.46 | ACQ/DIS | 0.00% | 0.00 | Jan 31 - Feb 01 | View |
| Jan 13, 2023 | Pierre Legault | — | 0.00 | $18.95 | -$615.80K | SELL-OPTIONS | 0.00% | 32.00K | Jan 12 - Jan 13 | View |
| Dec 02, 2022 | Peter Ordentlich | CHIEF SCIENTIFIC OFFICER | 0.00 | $15.71 | -$466.64K | SELL-OPTIONS | 0.00% | 265.00 | Dec 01 - Dec 02 | View |
| Oct 07, 2022 | Keith Katkin | — | 0.00 | $17.05 | -$529.23K | SELL-OPTIONS | 0.00% | 32.00K | Oct 06 | View |
| Oct 07, 2022 | Michael A Metzger | CHIEF EXECUTIVE OFFICER | 0.00 | $17.03 | -$268.16K | SELL-OPTIONS | 0.00% | 17.66K | Oct 06 | View |
| Oct 04, 2022 | Michael A Metzger | CHIEF EXECUTIVE OFFICER | 0.00 | $16.89 | -$548.74K | SELL-OPTIONS | 0.00% | 17.66K | Sep 30 - Oct 04 | View |
| Oct 04, 2022 | Keith Katkin | — | 0.00 | $16.58 | -$69.53K | SELL-OPTIONS | 0.00% | 32.00K | Sep 30 - Oct 04 | View |
| Sep 21, 2022 | Briggs Morrison | PRESIDENT, HEAD R&D | 0.00 | $17.00 | -$2.12M | SELL-OPTIONS | 0.00% | 17.84K | Sep 19 - Sep 20 | View |
| Sep 16, 2022 | Briggs Morrison | PRESIDENT, HEAD R&D | 0.00 | $15.77 | -$4.40M | SELL-OPTIONS | 0.00% | 17.84K | Sep 14 - Sep 16 | View |
| Sep 16, 2022 | Dennis Podlesak | — | 0.00 | $15.20 | -$1.40M | SELL-OPTIONS | 0.00% | 75.76K | Sep 15 - Sep 16 | View |
| Aug 26, 2022 | Peter Ordentlich | CHIEF SCIENTIFIC OFFICER | 265.00 | $15.72 | -$464.09K | SELL-OPTIONS | ∞ | 265.00 | Jul 29 - Aug 24 | View |
| Aug 09, 2022 | Pierre Legault | — | 0.00 | $16.12 | -$331.06K | SELL-OPTIONS | 0.00% | 32.00K | Aug 05 | View |
| Jul 27, 2022 | Michael A Metzger | CHIEF EXECUTIVE OFFICER | 0.00 | $13.72 | -$463.77K | SELL-OPTIONS | 0.00% | 17.66K | Jul 25 | View |
| Jul 08, 2022 | Michael A Metzger | CHIEF EXECUTIVE OFFICER | 0.00 | $13.73 | -$222.01K | SELL-OPTIONS | 0.00% | 17.66K | Jul 06 - Jul 07 | View |
| Jul 05, 2022 | Briggs Morrison | PRESIDENT, HEAD R&D | 0.00 | $13.10 | -$734.93K | SELL-OPTIONS | 0.00% | 17.84K | Jul 01 | View |
| Apr 05, 2022 | Briggs Morrison | PRESIDENT, HEAD R&D | -30.50K | $14.19 | -$1.02M | SELL | -63.10% | 17.84K | Apr 01 - Apr 04 | View |
| Feb 03, 2022 | Peter Ordentlich | CHIEF SCIENTIFIC OFFICER | 0.00 | $14.52 | -$6.02K | ACQ/DIS | 0.00% | 0.00 | Jan 31 - Feb 01 | View |
| Feb 03, 2022 | Alexander Nolte | CHIEF ACCOUNTING OFFICER | 0.00 | $14.52 | -$4.12K | ACQ/DIS | 0.00% | 0.00 | Jan 31 - Feb 01 | View |
| Dec 22, 2021 | Pierre Legault | — | 0.00 | $14.54 | -$617.74K | SELL-OPTIONS | 0.00% | 16.00K | Dec 20 - Dec 22 | View |
| Dec 20, 2021 | Briggs Morrison | CHIEF EXECUTIVE OFFICER | 0.00 | $15.45 | -$319.92K | SELL-OPTIONS | 0.00% | 48.34K | Dec 17 | View |
| Dec 20, 2021 | Michael A Metzger | PRESIDENT AND COO | 0.00 | $13.79 | -$1.05M | SELL-OPTIONS | 0.00% | 17.66K | Dec 16 - Dec 20 | View |
| Dec 15, 2021 | Michael A Metzger | PRESIDENT AND COO | 0.00 | $12.74 | -$462.28K | SELL-OPTIONS | 0.00% | 17.66K | Dec 13 | View |
| Nov 19, 2021 | Fabrice Egros | — | 0.00 | $13.48 | -$127.74K | SELL-OPTIONS | 0.00% | 16.00K | Nov 18 | View |
| Oct 27, 2021 | Michael A Metzger | PRESIDENT AND COO | 0.00 | $13.18 | -$728.96K | SELL-OPTIONS | 0.00% | 17.66K | Oct 25 - Oct 26 | View |
| Sep 28, 2021 | Michael A Metzger | PRESIDENT AND COO | 0.00 | $13.36 | -$300.89K | SELL-OPTIONS | 0.00% | 17.66K | Sep 27 | View |
| Sep 22, 2021 | Michael A Metzger | PRESIDENT AND COO | 0.00 | $13.21 | -$439.61K | SELL-OPTIONS | 0.00% | 17.66K | Sep 20 - Sep 22 | View |
| Sep 21, 2021 | Briggs Morrison | CHIEF EXECUTIVE OFFICER | 0.00 | $13.63 | -$904.77K | SELL-OPTIONS | 0.00% | 48.34K | Sep 17 - Sep 20 | View |
| Sep 15, 2021 | Michael A Metzger | PRESIDENT AND COO | 0.00 | $13.16 | -$726.83K | SELL-OPTIONS | 0.00% | 17.66K | Sep 13 - Sep 14 | View |
| Aug 20, 2021 | Fabrice Egros | — | 0.00 | $11.82 | -$123.12K | SELL-OPTIONS | 0.00% | 16.00K | Aug 18 | View |
| May 20, 2021 | Fabrice Egros | — | 0.00 | $12.97 | -$154.65K | SELL-OPTIONS | 0.00% | 16.00K | May 18 | View |
| Apr 28, 2021 | Michael Meyers | SVP, CHIEF MEDICAL OFFICER | 500.00 | $15.46 | $7.73K | BUY | 3.30% | 15.67K | Apr 26 | View |
| Apr 22, 2021 | Dennis Podlesak | — | 13.97K | $14.11 | $197.08K | BUY | 47.62% | 43.30K | Apr 22 | View |
| Mar 03, 2021 | Fabrice Egros | — | 0.00 | $15.33 | -$183.89K | SELL-OPTIONS | 0.00% | 16.00K | Mar 01 | View |
| Feb 10, 2021 | Briggs Morrison | CHIEF EXECUTIVE OFFICER | 0.00 | $13.87 | -$469.28K | SELL-OPTIONS | 0.00% | 48.34K | Feb 08 | View |
| Feb 03, 2021 | Michael A Metzger | PRESIDENT AND COO | 0.00 | $13.69 | -$194.80K | SELL-OPTIONS | 0.00% | 17.66K | Feb 01 | View |
| Dec 03, 2020 | Michael A Metzger | — | 0.00 | $15.08 | -$236.51K | OPTION EXERCISE | 0.00% | 17.66K | Dec 01 | View |
| Nov 25, 2020 | Peter Ordentlich | — | 0.00 | $13.12 | -$601.81K | OPTION EXERCISE | 0.00% | 0.00 | Nov 23 | View |
| Nov 12, 2020 | Briggs Morrison | — | 0.00 | $13.62 | -$1.03M | OPTION EXERCISE | 0.00% | 46.56K | Nov 09 - Nov 10 | View |
| Nov 06, 2020 | Michael A Metzger | — | 0.00 | $13.76 | -$1.31M | OPTION EXERCISE | 0.00% | 17.66K | Nov 04 | View |
| Feb 05, 2020 | Briggs Morrison | — | 12.50K | $8.00 | $100.00K | PURCHASE | 39.81% | 43.90K | Feb 04 | View |
| Oct 11, 2019 | Briggs Morrison | CHIEF EXECUTIVE OFFICER | 11.00K | $5.40 | $59.40K | BUY | 53.92% | 31.40K | Oct 10 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.